GM24463
LCL from B-Lymphocyte
Description:
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A
LAMININ, ALPHA-2; LAMA2
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific PIGI Consented Sample |
Class |
Congenital Muscle Diseases |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Country of Origin
|
USA
|
Family History
|
Y
|
Relation to Proband
|
proband
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
LAMA2 |
Chromosomal Location |
6q22-q23 |
Allelic Variant 1 |
; MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A |
Identified Mutation |
c.4198C>T (p.Arg1400Ter) |
|
Gene |
LAMA2 |
Chromosomal Location |
6q22-q23 |
Allelic Variant 1 |
; Muscular dystrophy, congenital, merosin deficient or partially deficient |
Identified Mutation |
c.6706A>C (p.Arg2236Arg) |
Remarks |
Clinically affected; hypotonia with weakness; dysphasia; torticollis; motor functions achieved: held head up without assistance at 2-3 months, turned in bed at 6 months, sat without assistance at 9 months, cannot stand without assistance, but can walk with assistance at 3 years; CMD confirmed by muscle biopsy; heterozygous for a mutation in exon 29 of the LAMA2 gene for an undocumented mutation in C.4198 C>T, which is predicted to result in a premature protein termination (p. ARG1400stop), also heterozygous for a mutation in exon 47 C.6706 A>C: p. ARG2236 ARG mutation of unknown significance; elevated CPK of 1388; treatments include: supplemental oxygen during sleep; family history includes one affected sister. |
Split Ratio |
1:2 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|